US 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted A61PA61P25/00A61P29/00
Quick answer
US patent 12421231 (Azaindole derivatives and their use as ERK kinase inhibitors) held by AGV Discovery expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AGV Discovery
- Grant date
- Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P25/00, A61P29/00, A61P31/18, A61P35/00